• Skip to main content

Parkinson’s Treatment Report

www.ParkinsonsTreatmentReport.com

MEDI1341

Single Ascending Dose Study of MEDI1341 in Healthy Volunteers

May 13, 2019

https://clinicaltrials.gov/ct2/show/NCT03272165?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=04%2F29%2F2019&lupd_d=14&sort=nwst

STUDY TITLE:
Single Ascending Dose Study of MEDI1341 in Healthy Volunteers

DESCRIPTION:
Condition:   Parkinson’s Disease
Interventions:   Drug: MEDI1341;   Drug: Placebo
Sponsors:   AstraZeneca;   Covance;   MMS Holdings, Inc;   Catalent
Recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT03272165

FIRST POSTED:
Tue, 05 Sep 2017 12:00:00 EDT

LAST UPDATE POSTED:
05/13/19 07:43AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03272165?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=04%2F29%2F2019&lupd_d=14&sort=nwst

Powered by Urgent Research

Copyright © 2025 Urgent Research